ROYAL BANK OF CANADA - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$18,757,000
+412.5%
220,582
+113.6%
0.01%
+600.0%
Q2 2020$3,660,000
+171.3%
103,274
+3.2%
0.00%0.0%
Q1 2020$1,349,000
-41.1%
100,096
-7.6%
0.00%0.0%
Q4 2019$2,291,000
+123.5%
108,276
+40.2%
0.00%
Q3 2019$1,025,000
-7.2%
77,243
-3.1%
0.00%
Q2 2019$1,105,000
-25.2%
79,708
+3.7%
0.00%
-100.0%
Q1 2019$1,477,000
+1045.0%
76,871
+751.5%
0.00%
Q4 2018$129,000
-97.2%
9,028
-95.9%
0.00%
-100.0%
Q3 2018$4,634,000
-29.4%
222,466
-19.8%
0.00%
-33.3%
Q2 2018$6,567,000
+187.5%
277,406
+77.5%
0.00%
+200.0%
Q1 2018$2,284,000
+4052.7%
156,326
+4518.2%
0.00%
Q4 2017$55,000
-70.4%
3,385
-74.6%
0.00%
Q3 2017$186,000
+158.3%
13,311
+63.2%
0.00%
Q2 2017$72,000
+14.3%
8,156
-16.8%
0.00%
Q1 2017$63,000
+40.0%
9,799
-20.9%
0.00%
Q4 2016$45,000
+87.5%
12,386
+65.0%
0.00%
Q3 2016$24,000
+41.2%
7,506
-1.3%
0.00%
Q2 2016$17,000
-10.5%
7,607
+3.6%
0.00%
Q1 2016$19,000
-47.2%
7,341
-36.7%
0.00%
Q4 2015$36,000
-21.7%
11,594
-57.1%
0.00%
Q3 2015$46,000
-77.3%
27,026
-45.9%
0.00%
Q2 2015$203,000
+18.7%
50,001
+12.2%
0.00%
Q1 2015$171,000
+222.6%
44,565
+301.3%
0.00%
Q4 2014$53,000
+307.7%
11,106
+208.0%
0.00%
Q3 2014$13,000
+225.0%
3,606
+226.0%
0.00%
Q2 2014$4,000
-42.9%
1,106
+2.5%
0.00%
Q3 2013$7,0001,079
+2597.5%
0.00%
Q2 2013$0400.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders